Hemodialysis Market by Stage of Disease (CKD (chronic kidney disease), ESRD (End-Stage Renal disease), By End-user (Conventional Hemodialysis (In-centre hemodialysis), Home Hemodialysis, Others), By Geography, Size, Share and Global Report, Forecast 2021-2030

Industry Report and Statistics (Facts & Figures) - Number of Procedue Conducted by Disease Type & End-users

The global hemodialysis market will witness a robust CAGR of 5.1%, valued at $85.49 million in 2021, expected to appreciate and reach $130.36 million by 2030, confirms Strategic Market Research. While healthy kidneys perform various tasks in the body, including eliminating acid created by the cells and maintaining a healthy balance of water, minerals, and salts, the most important is urine production. When the kidney's performance drops below 10% to 15%, the kidneys can no longer filter the blood and produce urine, causing toxins and extra fluid to build up in the body. The findings of the National Kidney Foundation suggest that chronic kidney disease (CKD) affects 10% of the world's population. Statistics suggest that 80 % or more patients availing treatment for kidney failure belong to prosperous countries having universal health coverage and constitute a larger number of the senior population.

 

 

Types of Dialysis - Dialysis Is a Filtration Process in Which a Machine Purifies the Blood and Regulates Fluid and Electrolyte Symmetry and Balance When the Kidneys Fail to Do So. Dialysis Can Be Performed in Three Ways:

• Hemodialysis (HD): This process utilizes an artificial kidney (hemodialyzer) to filter blood. The filtered blood is then sent back to the body with the assistance of a machine. Treatment takes about 4 hours each time.

 

• Peritoneal dialysis (PD): In this process, the inner lining of the belly (peritoneum) acts as a natural filter, and a special fluid which is called dialysate flows through it. The dialysate absorbs the waste from the bloodstream and is drained out of the body. The process usually is performed at home and takes 4 to 6 hours.

 

• Continuous Renal Replacement Therapy (CRRT): The Process is a slower type of Hemodialysis that puts less stress on the heart. This therapy is used majorly in the ICU (intensive care unit) for people with chronic and acute kidney failure. Instead of doing it over 4 hours, CRRT is done 24 hours a day.

 

• Procedure: Hemodialysis involves removing blood from the body and filtering it through an artificial membrane known as a dialyzer (artificial kidney) before returning it to the entire body. Hemodialysis necessitates the creation of unique access to transport blood from the body to the dialyzer and back. Arteriovenous (AV) fistula, AV graft, and central venous catheter are the three forms of hemodialysis access. The AV fistula is the most commonly used vascular access.

 

Types of Hemodialysis

• Traditional (In-center hemodialysis): It requires hemodialysis treatments to be performed at a dialysis center. It is usually done three times a week for around four hours.

 

• Home Hemodialysis: Home hemodialysis (HHD) is a type of Hemodialysis performed at home to treat kidney failure, also called end-stage renal disease (ESRD). As per convenience Home Hemodialysis can be Nocturnal or Short Daily. The patient undergoes dialysis for around 8 hours while sleeping on Nocturnal Hemodialysis. A Short-Daily Hemodialysis is done six times a week for 2 hours each time.

 

Benefits of Performing Hemodialysis

• Helps to control the blood pressure of the body

• Maintains the proper balance of fluid and various minerals

• Improves the heart health

• Improves sleeping patterns and energy level

• Reduces cramping, headaches, and nausea

• Betters the quality of life and well-being

 

Key Industry Drivers - Rising Cases of Hypertension, Diabetes, ESRD, and Kidney Shortages

Crucial factors that augment the growth of the hemodialysis market are:

•  Rising cases of hypertension: Renal hypertension (Renal artery stenosis or renovascular hypertension) is a type of high blood pressure caused by the shrinking of the arteries that supply blood to the kidneys. When kidneys don't get enough blood, they produce a hormone that increases blood pressure. According to a journal published in Medscape, the prevalence of hypertension is expected to increase from 26% (2020) to 29% by 2025, driven largely by increases in economically developing nations.

 

• Prevalence of Diabetes: Over time, poorly controlled diabetes can cause damage to blood vessel clusters in the kidneys leading to kidney damage and causing high blood pressure. High blood pressure can cause further damage to the kidney. According to Diabetes Atlas 2021 of The International Diabetes Federation (IDF), Approximately 537 million adults (20-79 years) live with diabetes. The diabetic population will rise from 537 million (2021) to 643 million by 2030 and 783 million by 2045.

 

• End-stage renal disorder (ESRD):  End-Stage Renal Disease is a medical condition in which an individual's kidneys stop functioning permanently, resulting in a regular course of long-term dialysis or a kidney transplant to maintain a healthy life. According to the research published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Nearly 786,000 people in the US live with ESKD, also known as an end-stage renal disease (ESRD), with 71% on dialysis and 29% with a kidney transplant.  

 

• Shortage of kidney transplants: The need for donor's kidneys is rising at 8% per year, yet their availability has not grown to match. The reasons include Compatibility issues, lack of registered donors, and difficulty in obtaining organs from registered donors. According to organdonor.gov, there are currently over 106,000 people waiting for lifesaving organ transplants in the US. Of these, 90,443 await kidney transplants. For an individual's first kidney transplant, the median wait time is 3.6 years.

 

Restraints - Side-effects, High Cost, and Fatigue

• Side Effects: There may be side effects of Hemodialysis, such as hypotension, risk of developing sepsis, bone and joint pain, anxiety, insomnia, and erectile dysfunction. 

 

• High cost: Hemodialysis consumes a lot of resources as the equipment, and the materials are quite expensive. In addition, dialysis needs trained staff to assist. According to the US Renal Data System, one year of Hemodialysis can total $72,000; a year of peritoneal dialysis can cost about $53,000.

 

• Fatigue: A majority of patients receiving in-center hemodialysis experience symptoms such as feeling washed out, fatigue, and cramping. Journals published by BMC (Biomed Central) estimate that more than 43% feel fatigued after performing Hemodialysis.

 

Opportunities 

Rising rates of acute renal failure: Diabetes, high blood pressure, exposure to high doses of medicine, acute dehydration, and kidney trauma which cause kidney failure, are increasing at an alarming rate. The findings of the CDC estimate that chronic kidney disease affects 15% of adults (37 million individuals) in the United States.

 

High Demand: The global dialysis population is growing rapidly, especially in low-income and middle-income countries. Increased awareness of CKD and treatment options will contribute to the growing demand for dialysis. Global Kidney Health Atlas 2019 of the International Society of Nephrology estimates that the demand and supply gaps for Hemodialysis will further increase from 7.1 million (2010) to 9.1 million by 2030. 

  

Technological Advancements: New technologies like Remote patient management (RPM) that allows for real-time examination of a patient's clinical status from their home are gaining significance. RPM technology Uses biotech sensors and data from remote patients and transmits clinical information collected by patients to healthcare providers in real-time, allowing real-time monitoring of patient's clinical status. Such technologies provide immense opportunities to facilitate existing kidney patients on dialysis worldwide. According to the recent National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates, Nearly 786,000 people in the United States live with ESKD, also known as an end-stage renal disease (ESRD), with 71% on dialysis and 29% with a kidney transplant.  

 

Market Analysis Of Different Segments Covered in the Report

Based on Stage of Disease 

• CKD (Chronic Kidney Disease)

• ESRD (End-Stage Renal disease)

 

Based on End-user

• Conventional Hemodialysis (In-centre hemodialysis)

• Home Hemodialysis

• Others

 

Regional Coverage Analysis

North America

• The U.S.

• Canada

• Mexico

• Rest of North America

 

Europe

• France

• Germany

• U.K

• Spain

• Italy

• Rest of Europe

 

Asia Pacific

• China

• India

• Japan

• Australia

• Rest of APAC

 

LAMEA

• Brazil

• Saudi Arabia

• South Africa

• Rest of LAMEA

 

 

Segments Analysis & Insights

By Stage of Disease, CKD (Chronic Kidney Disease) had the largest revenue share. End-stage renal disease (ESRD) is the final, irreversible chronic kidney disease stage. Dialysis or kidney transplantation is required for patients with end-stage renal failure. As per the United States Renal Data System's Annual Data Report, The total Medicare spending on CKD ($84 billion) and ESRD ($36 billion) patients was more than $120million in 2017.

 

Based on end-User, Conventional (in-centre) hemodialysis is poised to grab a large portion of the industry due to the massive adoption of hemodialysis therapy as compared to peritoneal dialysis among chronic kidney disease and end-stage renal disease patients. With in-center hemodialysis (HD), a patient goes to a dialysis center where a staff of nurses and technicians administer the treatment.

 

Based on Region, North America is poised to lead the Global Hemodialysis Market share owing to improved healthcare infrastructure, government initiatives, public awareness campaigns, and key market participants. According to the University of California San Francisco 2018, 2 million people worldwide (750,000 people in the US) suffer from kidney failure, and the incidence rate of the disease is increasing at a rate of 5-7% per year.

 

Hemodialysis Market Report Coverage

Report Attributes	Details
Forecasted Period	2021 - 2030
The market size value in 2021	USD 85.49 Million
The revenue forecast in 2030	USD 130.36 Million
Growth rate	CAGR of 4.7%
The base year for estimation	2021
Historical data	2017 – 2020
Unit	USD Million, CAGR (2021 - 2030)
Segmentation Analysis	By End User, By stage of Disease, and By Region
By End-User	Conventional Hemodialysis (In-center Hemodialysis), Home Hemodialysis and Others
By Stage of Disease	CKD(Chronic Kidney Disease) and ESRD (End-Stage Renal disease)
By Region	North America, Europe, Asia-Pacific, MEA, Latin America, Africa
Country Scope	US, Mexico, Canada, Germany, UK, France, China, Japan, India, etc.
Company Usability Profiles	Fresenius, DaVita Inc, Baxter & Gambro, B Braun, Dickinson and Company, NxStage, Nikkiso, Fresenius Medical Care AG, Cantel Medical Corp, Toray, Nipro, Bellco, Asahi Kasei, KGaA, WEGO, Shanwaishan and Jihua

 

Global Hemodialysis Market Competitive Landscape Analysis

The global hemodialysis market report outlines the key competitor analysis operating globally. The comparison is based on total sales generated, Overview of the company, production analysis, value chain optimization, industry share financials, key investments by venture capitalists, company strengths and weaknesses, global presence, the structure of the start-up ecosystem, mergers & acquisitions, production capacity, market potential, SWOT Analysis, Supply Chain Analysis, R&D investment, Product mapping, few among others.

• Fresenius

• DaVita Inc

• Baxter & Gambro

• Braun

• Becton, Dickinson and Company

• NxStage

• Nikkiso

• Toray

• Nipro

• Asahi Kasei

• Merck KGaA

• WEGO

• Jihua

 

 

Key Recent Developments

• In April 2022, The National Kidney Foundation (NKF) Innovation Fund (Launched in April 2022) made its first dialysis investment in Kuleana Technology, Inc. (Kuleana), a Seattle, Washington-based startup. Kuleana is working on ground-breaking portable hemodialysis equipment that won't need to be connected to a water supply or use complicated sorbents. This technology will be more effective than existing dialysis since it will allow patients to dialyze on the go, allowing millions of patients worldwide to dialyze whenever and wherever they want.

 

• In March 2022, U.S. Renal Care announced the establishment of four new dialysis centers in Fort Myers. U.S. Renal Care (USRC), a prominent dialysis provider serving more than 26,000 Americans with kidney disease, will install four new in-center hemodialysis facilities in Southwest Florida. U.S. Renal Care, Inc. works with nephrologists and health systems to provide a full spectrum of services for patients with chronic and acute renal illness, including best-in-class in-center and home dialysis. 

 

• In October 2021, The Centers for Medicare & Medicaid Services (CMS) updated the ESRD PPS payment rates and made modifications to the ESRD Quality Incentive Program (QIP) and the ESRD Treatment Choices (ETC) Model. The initiative aims to incentivize dialysis facilities and healthcare professionals to reduce gaps in rates of household and home kidney dialysis and kidney transplants among end-stage renal disease patients having lower socioeconomic status, making it one of the CMS Innovation Center's first models to explicitly address health equality.

 

• In June 2021, Strive Health and Outset Medical, two health-tech companies, have teamed up to redefine renal treatment. Strive Health, a leader in value-based kidney care, and Outset Medical, Inc, a dialysis technology innovator, have forged a partnership to support both companies' efforts to change the renal care paradigm. Strive Health will employ Outset's Tablo Hemodialysis System to improve patient access to home hemodialysis. Strive Health is a rapidly developing organization focused on delaying renal disease progression and minimizing costly hospitalizations with a proprietary whole-patient solution.

 

Various Products the Key Manufacturers Develop:

Products	Key Functions	Device Manufacturers
2008K@Home	A hemodialysis Machine that cleans the blood by passing it through a filter called a dialyzer	Fresenius Medical Care
Dialog+	Fore home hemodialysis.	B.Braun
MDS 101	Dialysis equipment system for ultrafiltration and simplified procedures.	Asahi Kasei Corp
AK 98 machine	Expanded hemodialysis (HDx) therapy enabled by Theranova membrane.	Baxter International Inc.